2 - 3 September 2025 | Porto Alegre/RS

The II National Immunotherapy Symposium is a unique event that brings together professionals from different areas of health to discuss the latest trends and advances in immunotherapy with a focus on oncology and precision medicine.

HOT TOPICS

Development of new Brazilian monoclonal antibodies
Clinical studies with CAR-T cells produced in Brazil
Precision oncology with national technology
Identification of new therapeutic targets

Place

Federal University of Health Sciences of Porto Alegre (UFCSPA)

Sarmento Leite, 245, CEP: 90050-170

Building 2, third floor, Moacyr Scliar Theater

Soon!

Preliminary Program

02 de setembro de 2025:

08:30 - Registration
09:00-10:00 - Course
10:00-10:30 - Break
10:30-11:30 - Course
11:30-12:30 - Course
12:45-13:45 - Satellite Symposium
14:00-14:15 - Official Opening
14:15-15:45 - Round Table 1
15:45-16:15 - Oral Session: presentation of selected papers
16:15-16:30 - Break and visit to the exhibition and poster area
16:30-18:00 - Round Table 2
18:00-19:30 - Happy Poster

03 de setembro de 2025:

08:00 - Accreditation
08:30-10:00 - Round Table 3
10:00-10:30 - Break
10:30-12:00 - Round Table 4
12:00-13:00 - Satellite Symposium
13:30-15:00 - Round Table 5
15:00-15:30 - Closing Conference
15:30-16:30 - Break and visit to the exhibition and poster area
16:30-18:00 - ABRIT Assembly
18:00 - Closing

Confirmed speakers

Experimental research

Adriana Bonomo (FIOCRUZ/IOC)
Andre Vale (UFRJ)
Andreia Maranhão (UNB)
Cristina Bonorino (UFCSPA)
Elizandra Braganhol (UFCSPA)
Helder Nakaya (Einstein)
João Viola (ICB USP)
José Alexandre Barbuto (USP)
Kelly Magalhães (UNB)
Kenneth Gollob (EINSTEIN)
Larissa Cunha (FMUSPRP)
Leda Castilho (UFRJ)
Mariana Boroni (INCA)
Martin Bonamino (INCA)
Rodrigo Nalio (IDOR e FMUSP)

Clinical research

Andreia Mello (INCA)
Caroline Albuquerque (CPO -PUCRS)
Fabio Franke (Unimed e CACON)
Leandro Machado Colli (USP-FMRP)
Lucila Kerbauy (Einstein)
Mariano Zalllis (Instituto Oncoclinicas e UFRJ)
Rafael Vargas (ISCMPA)
Stephan Soder (ISCMPA e HMV)

Submission Rules

SOON!

Submission deadline: 08.08.2025
Results announcement: 15.08.2025

Submission rules

Submit references separately from the abstract;
Abstract in accordance with ABNT;
References in the abstract must be restricted to a minimum, only numbers;
Abstracts must not exceed two thousand (2,000) characters, including spaces;
Abstract titles must not exceed 255 characters, including spaces;
The names, e-mails, CPF (only for Brazilians), passport numbers and affiliations of all authors must be included in the abstract submission form;
Abbreviations must be defined when they are mentioned for the first time in the abstract;
Abstracts must not contain tables, graphs or images.

Please name the email subject as:
"II National Immunotherapy Symposium - Abstract Subimission"

Evaluation Criteria

All approved abstracts must be accompanied by the respective presentation in poster format. The poster must be presented, obligatorily, by the author responsible for submitting the abstract (PRESENTER), at the time and place established by the event organizers.
The presentations will be evaluated by an independent committee, based on the following criteria:
Relevance of the topic
Originality and innovation
Clarity and objectivity in the presentation
Methodological and scientific quality of the research
Conclusions and contributions to the field of knowledge